These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 29608680)
1. Extended vs Bolus Infusion of Broad-Spectrum β-Lactams for Febrile Neutropenia: An Unblinded, Randomized Trial. Ram R; Halavy Y; Amit O; Paran Y; Katchman E; Yachini B; Kor S; Avivi I; Ben-Ami R Clin Infect Dis; 2018 Sep; 67(8):1153-1160. PubMed ID: 29608680 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE). Laporte-Amargos J; Gudiol C; Arnan M; Puerta-Alcalde P; Carmona-Torre F; Huguet M; Albasanz-Puig A; Parody R; Garcia-Vidal C; Del Pozo JL; Batlle M; Tebé C; Rigo-Bonnin R; Muñoz C; Padullés A; Tubau F; Videla S; Sureda A; Carratalà J Trials; 2020 May; 21(1):412. PubMed ID: 32423462 [TBL] [Abstract][Full Text] [Related]
3. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams. Paul M; Yahav D; Bivas A; Fraser A; Leibovici L Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD005197. PubMed ID: 21069685 [TBL] [Abstract][Full Text] [Related]
4. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients. Marie JP; Marjanovic Z; Vekhoff A; Bouvet A; Chast F; Levy V; Baudard M; Legrand O; Rio B; Delmer A; Zittoun R Support Care Cancer; 1999 Mar; 7(2):89-94. PubMed ID: 10089089 [TBL] [Abstract][Full Text] [Related]
5. Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients. Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A J Pediatr Hematol Oncol; 2009 Apr; 31(4):270-3. PubMed ID: 19346879 [TBL] [Abstract][Full Text] [Related]
6. Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia. Wrenn RH; Cluck D; Kennedy L; Ohl C; Williamson JC J Oncol Pharm Pract; 2018 Apr; 24(3):170-175. PubMed ID: 28077047 [TBL] [Abstract][Full Text] [Related]
7. PIPERACILLIN/TAZOBACTAM IN CONTINUOUS INFUSION VERSUS INTERMITTENT INFUSION IN CHILDREN WITH FEBRILE NEUTROPENIA. Solórzano-Santos F; Quezada-Herrera A; Fuentes-Pacheco Y; Rodríguez-Coello G; Aguirre-Morales CE; Izelo-Flores D; Muñoz-Hernández O; Miranda-Novales MG; Labra-Zamora MG Rev Invest Clin; 2019; 71(4):283-290. PubMed ID: 31448789 [TBL] [Abstract][Full Text] [Related]
8. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial. Sanz MA; López J; Lahuerta JJ; Rovira M; Batlle M; Pérez C; Vázquez L; Julià A; Palau J; Gutiérrez M; Capote FJ; Ramos F; Benlloch L; Larrea L; Jarque I; J Antimicrob Chemother; 2002 Jul; 50(1):79-88. PubMed ID: 12096010 [TBL] [Abstract][Full Text] [Related]
9. Parameters influencing the pharmacokinetics/pharmacodynamics of piperacillin/tazobactam in patients with febrile neutropenia and haematological malignancy: a prospective study. Benech N; Dumitrescu O; Conrad A; Balsat M; Paubelle E; Ducastelle-Lepretre S; Labussière-Wallet H; Salles G; Cohen S; Goutelle S; Ader F; J Antimicrob Chemother; 2019 Sep; 74(9):2676-2680. PubMed ID: 31219562 [TBL] [Abstract][Full Text] [Related]
10. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients. Hess U; Böhme C; Rey K; Senn HJ Support Care Cancer; 1998 Jul; 6(4):402-9. PubMed ID: 9695210 [TBL] [Abstract][Full Text] [Related]
11. A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients. Kamonrattana R; Sathitsamitphong L; Choeyprasert W; Charoenkwan P; Natesirinilkul R; Fanhchaksai K Asian Pac J Cancer Prev; 2019 Sep; 20(9):2733-2737. PubMed ID: 31554370 [TBL] [Abstract][Full Text] [Related]
12. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial. Aguilar-Guisado M; Espigado I; Martín-Peña A; Gudiol C; Royo-Cebrecos C; Falantes J; Vázquez-López L; Montero MI; Rosso-Fernández C; de la Luz Martino M; Parody R; González-Campos J; Garzón-López S; Calderón-Cabrera C; Barba P; Rodríguez N; Rovira M; Montero-Mateos E; Carratalá J; Pérez-Simón JA; Cisneros JM Lancet Haematol; 2017 Dec; 4(12):e573-e583. PubMed ID: 29153975 [TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. Bliziotis IA; Michalopoulos A; Kasiakou SK; Samonis G; Christodoulou C; Chrysanthopoulou S; Falagas ME Mayo Clin Proc; 2005 Sep; 80(9):1146-56. PubMed ID: 16178494 [TBL] [Abstract][Full Text] [Related]
14. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III. Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514 [TBL] [Abstract][Full Text] [Related]
15. [Piperacillin/tazobactam plus amikacin vs. piperacilin/tazobactam: treatment for children with febrile neutropenia]. Pacheco-Rosas DO; Peregrino-Bejarano L; López-Aguilar JE; Juan-Shum L; Miranda-Novales MG Rev Med Inst Mex Seguro Soc; 2019 Jul; 57(2):65-73. PubMed ID: 31617992 [TBL] [Abstract][Full Text] [Related]
16. Meropenem versus piperacillin-tazobactam as empiric therapy for febrile neutropenia in pediatric oncology patients. Sezgin G; Acipayam C; Ozkan A; Bayram I; Tanyeli A Asian Pac J Cancer Prev; 2014; 15(11):4549-53. PubMed ID: 24969883 [TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized study comparing cefozopran with piperacillin-tazobactam plus ceftazidime as empirical therapy for febrile neutropenia in children with hematological disorders. Sato T; Kobayashi R; Yasuda K; Kaneda M; Iguchi A; Kobayashi K Pediatr Blood Cancer; 2008 Dec; 51(6):774-7. PubMed ID: 18661495 [TBL] [Abstract][Full Text] [Related]
18. Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison. Gorschlüter M; Hahn C; Fixson A; Mey U; Ziske C; Molitor E; Horré R; Sauerbruch T; Marklein G; Schmidt-Wolf IG; Glasmacher A Support Care Cancer; 2003 Jun; 11(6):362-70. PubMed ID: 12690546 [TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia: A systematic review and Bayesian network meta-analysis. Tan X; Li Y; Xi J; Guo S; Su H; Chen X; Liang X Medicine (Baltimore); 2021 Dec; 100(50):e27266. PubMed ID: 34918626 [TBL] [Abstract][Full Text] [Related]
20. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient. Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]